# CD300LG

## Overview
CD300LG is a gene that encodes the CD300 molecule-like family member g, a type-I transmembrane protein that is part of the CD300 family. This protein is characterized by its immunoglobulin-like domain and mucin-like domain, which are involved in immune regulation and cellular interactions. CD300LG is predominantly expressed in endothelial cells of small blood vessels, with notable expression in the heart, placenta, adipose tissue, and skeletal muscle. Functionally, the protein plays a role in lipid storage, glucose metabolism, and immune processes, including lymphocyte rolling and immunoglobulin transport. It has been identified as a novel exerkine, linking it to metabolic adaptations to exercise. Clinically, variations in the CD300LG gene are associated with metabolic syndrome, cardiovascular conditions, and immune-related diseases, underscoring its significance in both metabolic and immune health (Takatsu2006CD300; Støy2015ReducedCD300LGmRNA; Jiang2013A).

## Structure
CD300LG is a type-I membrane protein characterized by a unique structure that includes a V-type immunoglobulin (Ig) domain and a classical mucin-like domain. It is O-glycosylated, which affects its epitope and function, particularly in binding L-selectin to mediate lymphocyte rolling under physiological shear stress (Jiang2013A). The protein is expressed on the endothelial cells of small blood vessels, with the highest expression in the heart (Jiang2013A).

The CD300LG gene produces at least four isoforms in both humans and mice, resulting from alternative splicing of the mucin-like domain. These isoforms vary in amino acid length, with the mouse isoforms named CD300LG-d, -g, -b, and -a, having lengths of 415, 371, 331, and 287 amino acids, respectively (Takatsu2006CD300; Jiang2013A). The human isoforms have a similar genomic structure but feature a shorter cytoplasmic tail compared to their mouse counterparts (Takatsu2006CD300).

CD300LG is part of the CD300 family, which includes proteins with immunoglobulin-like domains involved in immune regulation. The protein's Ig domain shows approximately 35% identity to those of the polymeric Ig receptor (pIgR) and Fca/lR (Takatsu2006CD300).

## Function
The CD300LG gene encodes a protein that is part of the CD300 family of membrane-bound proteins, which are involved in recognizing and interacting with extracellular lipids. This protein is expressed in various tissues, with the highest levels found in the placenta, adipose tissue, and skeletal muscle (Støy2015ReducedCD300LGmRNA). CD300LG is implicated in lipid storage and glucose metabolism, particularly in skeletal muscle, where it may influence lipid accumulation and insulin sensitivity (Støy2015ReducedCD300LGmRNA). 

The protein is also expressed on capillary endothelium, where it is involved in transcytosis, a process that facilitates the transport of molecules across endothelial cells. CD300LG can bind and internalize immunoglobulins such as IgA2 and IgM, suggesting a role in immune function and molecular transport (Takatsu2006CD300). 

In the context of physical activity, CD300LG has been identified as a novel exerkine, potentially linking it to glucose homeostasis. Exercise-induced increases in CD300LG levels are associated with improvements in insulin sensitivity, indicating its role in metabolic adaptations to exercise (LeeØdegård2024Serum). These functions highlight CD300LG's involvement in both metabolic and immune processes.

## Clinical Significance
Mutations and alterations in the CD300LG gene have been linked to several metabolic and cardiovascular conditions. The Arg82Cys polymorphism in CD300LG is associated with metabolic syndrome components, such as decreased fasting serum high-density lipoprotein (HDL) cholesterol levels and increased fasting serum triglyceride levels. Carriers of this polymorphism exhibit reduced CD300LG mRNA expression in adipose tissue and skeletal muscle, increased lipid accumulation in skeletal muscle, and impaired glucose metabolism, which are risk factors for type 2 diabetes and cardiovascular diseases (Støy2015ReducedCD300LGmRNA).

The CD300LG gene is also implicated in blood pressure regulation. Male carriers of the CD300LG rs72836561 CT variant have higher 24-hour ambulatory systolic and diastolic blood pressure compared to non-carriers, suggesting a potential role in hypertension (Støy2014Blood).

Additionally, the CD300LG gene has been associated with IgA nephropathy (IgAN). The SNP rs12453522 in CD300LG is linked to an increased risk of developing IgAN in males, indicating a possible role in immune-related kidney disease (Bertinetto2011Search). These findings highlight the clinical significance of CD300LG in various metabolic, cardiovascular, and immune conditions.

## Interactions
CD300LG is involved in specific interactions with immunoglobulins, particularly IgA2 and IgM. In studies using HeLa cells, CD300LG was shown to bind and internalize human IgA2 and mouse IgM efficiently, while mouse IgA and human IgA1 were internalized less efficiently, and mouse IgG did not bind at all. This suggests that IgA and IgM may serve as ligands for CD300LG, indicating a potential role in immunoglobulin transport or signaling (Takatsu2006CD300).

CD300LG also interacts with lymphocyte L-selectin via its Ig domain, supporting lymphocyte rolling through its mucin-like domain. This interaction is crucial for the initial tethering and rolling step in leukocyte migration, highlighting CD300LG's role in inflammation and immune cell trafficking (Jiang2013A).

The protein is part of the CD300 family, which includes molecules that modulate immune responses through paired triggering and inhibitory receptor functions. These interactions are part of a complex signaling network that regulates leukocyte responses by coordinating inhibitory and stimulatory signals (Clark2009The). However, specific details on physical interactions with other proteins or nucleic acids beyond these mentioned interactions are not provided in the available context.


## References


[1. (Clark2009The) Georgina J. Clark, Xinsheng Ju, Courtney Tate, and Derek N.J. Hart. The cd300 family of molecules are evolutionarily significant regulators of leukocyte functions. Trends in Immunology, 30(5):209–217, May 2009. URL: http://dx.doi.org/10.1016/j.it.2009.02.003, doi:10.1016/j.it.2009.02.003. This article has 97 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.it.2009.02.003)

[2. (Støy2014Blood) Julie Støy, Niels Grarup, Arne Hørlyck, Liselotte Ibsen, Jørgen Rungby, Per Løgstrup Poulsen, Ivan Brandslund, Cramer Christensen, Torben Hansen, Oluf Pedersen, Niels Møller, and Ulla Kampmann. Blood pressure levels in male carriers of arg82cys in cd300lg. PLoS ONE, 9(10):e109646, October 2014. URL: http://dx.doi.org/10.1371/journal.pone.0109646, doi:10.1371/journal.pone.0109646. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0109646)

[3. (Takatsu2006CD300) Hiroyuki Takatsu, Koji Hase, Masumi Ohmae, Sayaka Ohshima, Koji Hashimoto, Naoko Taniura, Akitsugu Yamamoto, and Hiroshi Ohno. Cd300 antigen like family member g: a novel ig receptor like protein exclusively expressed on capillary endothelium. Biochemical and Biophysical Research Communications, 348(1):183–191, September 2006. URL: http://dx.doi.org/10.1016/j.bbrc.2006.07.047, doi:10.1016/j.bbrc.2006.07.047. This article has 33 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.bbrc.2006.07.047)

[4. (Jiang2013A) Xiaomei Jiang, Haibin Wang, Zhiguang Li, Dapeng Wei, Yuhui Yang, Xulei Zheng, Jianhong Bi, and Chongjie Zhang. A monoclonal antibody against a novel sialomucin cd300lg. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, 32(2):91–97, April 2013. URL: http://dx.doi.org/10.1089/mab.2012.0100, doi:10.1089/mab.2012.0100. This article has 3 citations.](https://doi.org/10.1089/mab.2012.0100)

[5. (Bertinetto2011Search) Francesca Eleonora Bertinetto, Francesc Calafell, Stefano Roggero, Rossella Chidichimo, Elena Garino, Cristina Marcuccio, Rosanna Coppo, Francesco Scolari, Giovanni Maria Frascá, Silvana Savoldi, Francesco Paolo Schena, and Antonio Amoroso. Search for genetic association between iga nephropathy and candidate genes selected by function or by gene mapping at loci igan2 and igan3. Nephrology Dialysis Transplantation, 27(6):2328–2337, November 2011. URL: http://dx.doi.org/10.1093/ndt/gfr633, doi:10.1093/ndt/gfr633. This article has 14 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/ndt/gfr633)

6. (LeeØdegård2024Serum) Serum proteomic profiling of physical activity reveals CD300LG as a novel exerkine with a potential causal link to glucose homeostasis. This article has 1 citations.

[7. (Støy2015ReducedCD300LGmRNA) Julie Støy, Ulla Kampmann, Annette Mengel, Nils E Magnusson, Niels Jessen, Niels Grarup, Jørgen Rungby, Hans Stødkilde-Jørgensen, Ivan Brandslund, Cramer Christensen, Torben Hansen, Oluf Pedersen, and Niels Møller. Reducedcd300lgmrna tissue expression, increased intramyocellular lipid content and impaired glucose metabolism in healthy male carriers of arg82cys incd300lg: a novel genometabolic cross-link betweencd300lgand common metabolic phenotypes. BMJ Open Diabetes Research &amp; Care, 3(1):e000095, August 2015. URL: http://dx.doi.org/10.1136/bmjdrc-2015-000095, doi:10.1136/bmjdrc-2015-000095. This article has 20 citations.](https://doi.org/10.1136/bmjdrc-2015-000095)